March 31 – April 3, 2019 Atlanta, Georgia Details: Exhibition booth #4322 Satellite symposium: Biomarker-driven Precision Oncology | March 31, 2019 Poster Presentations: Prognostic and predictive utility of copy number variations (CNVs) in circulating tumor DNA (ctDNA) from metastatic castration-resistant prostate cancer (mCRPC) patients https://www.abstractsonline.com/pp8/#!/6812/presentation/4859 Combined immunohistochemistry and NGS-based patient profiling for predicting anti-PD-1/PD-L1 therapy...

October 19-23, 2018 Munich, Germany Poster presentation: Circulating tumor DNA and RNA as an exploratory biomarker to evaluate GT0918 in a phase I/II clinical trial in mCRPC patients https://academic.oup.com/annonc/article/29/suppl_8/mdy269.162/5141769?searchresult=1